Katsuaki Ieguchi

Hatanodai, 1428555, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Single-Dose Toxicity Study of Self-Assembling A6K/Sodium Borocaptate (BSH) Peptide Nanotubes as a New Boron Delivery Agent for Boron Neutron Capture Therapy (BNCT) in Mice.

Single-Dose Toxicity Study of Self-Assembling A6K/Sodium Borocaptate (BSH) Peptide Nanotubes as a New Boron Delivery Agent for Boron Neutron Capture Therapy (BNCT) in Mice.

Journal: Cancers
Published: March 30, 2026

Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.

Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.

Journal: Frontiers in immunology
Published: March 10, 2026

Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study.

Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study.

Journal: Cancers
Published: June 12, 2025

Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers.

Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers.

Journal: Frontiers in oncology
Published: April 18, 2025

Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.

Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.

Journal: Frontiers in immunology
Published: November 15, 2024

Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model.

Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model.

Journal: Anticancer research
Published: October 19, 2023

Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors.

Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors.

Journal: Frontiers in immunology
Published: July 17, 2023

Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy.

Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy.

Journal: Oncology letters
Published: February 20, 2023

The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments.

The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments.

Journal: International journal of molecular sciences
Published: August 20, 2022

Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies.

Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies.

Journal: Biomedicines
Published: October 30, 2021

Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions.

Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions.

Journal: International journal of molecular sciences
Published: January 12, 2021

Eph/Ephrin Signaling in the Tumor Microenvironment.

Eph/Ephrin Signaling in the Tumor Microenvironment.

Journal: Advances in experimental medicine and biology
Published: October 30, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026